The trial in numbers
11801 patients randomised
348 patients randomised in the Golden hour in 2018
1199 Patients to recruit by 31 January 2019
Every minute counts
LATEST BLOG POSTS
14th October 2016 Click here for: CRASH-3 Trial [Generic] Protocol Version 2 Click here for: CRASH-3 Trial Protocol Amendment Summary Recruitment continues until we have 10,000 patients randomised within 3 hours of injury....
February 28th 2018 FURTHER REDUCE TIME TO TREATMENT AND INCREASE RECRUITMENT WITHIN THE LIFE-SAVING GOLDEN HOUR JANUARY 2018: The Independent Data Monitoring Committee reviewed the unblinded data for 10,000 patients and... They congratulate the global collaborators from all 29...
11,607 patients recruited
28 recruiting countries.
171 hospitals and medical centres.
ABOUT THE TRIAL
The CRASH3 trial aims to provide the research based information to prevent death by Traumatic Brain Injury.
The CRASH3 trial is testing whether tranexamic acid, a blood clot stabiliser that was discovered in Japan in the 1950’s, can become an essential tool for fighting excessive bleeding in the brain after Traumatic Brain Injury.more info
If you were a patient randomised into this trial and would like further information about your treatment, click below.
The staff at the hospital where you were being treated for your traumatic brain injury should have given you an information leaflet about the CRASH3 trial. If you have any questions or concerns about your treatment in the hospital, please contact your doctor in the first instance.more info